Mind Medicine (MNMD) Tops Q2 EPS by 7c

Mind Medicine (NASDAQ: MNMD) reported Q2 EPS of ($0.26), $0.07 better than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Mind Medicine (MNMD) click here.

You May Also Be Interested In

• Microsoft plans data center push to triple its computing power - Bloomberg
• UBS Starts CSE Global (CSE:SP) (CSYJF) at Buy
• Deutsche Bank Starts Associated British Foods (ABF:LN) (ASBFY) at Hold